The Supreme court decision on PTAB reviews was a

New Post Public Reply Private Reply Replies (2) Message Board
Hate Liars
508
The Supreme court decision on PTAB reviews was a significant milestone for Strikeforce's patents. The PTAB has performed two full reviews and ruled that the validity of Strikeforce's utility patents were valid on all challenges. The below article from June 12, 2017 from the well known journal IP Watchdog, is telling in terms of the consequences of the ruling.

IP Watchdog - Court to decide if Inter Partes Review is Unconstitutional
By Gene Quinn
June 12, 2017

Earlier today the United States Supreme Court granted certiorari in Oil States vs. Greene’s Energy Group, et al. From a substantive standpoint, this dispute is between the parties to an inter partes review (IPR) proceeding conducted by the Patent Trial and Appeal Board (PTAB). By taking this case the Supreme Court will once and for all address the constitutionality of having an Article I tribunal to extinguish patent rights.

There were three questions presented by Oil States in the petition for writ of certiorari. They were:

Whether inter partes review – an adversarial process used by the Patent and Trademark Office (PTO) to analyze the validity of existing patents – violates the Constitution by extinguishing private property rights through a non-Article III forum without a jury.
Whether the amendment process implemented by the PTO in inter partes review conflicts with Court’s decision in Cuozzo Speed Technologies, LLC v. Lee, 136 S.Ct. 2131 (2016), and congressional direction.
Whether the “broadest reasonable interpretation” of patent claims – upheld in Cuozzo for use in inter partes review – requires the application of traditional claim construction principles, including disclaimer by disparagement of prior art and reading claims in light of the patent’s specification.
The Supreme Court granted certiorari only on the first question, whether inter partes review violates the U.S. Constitution by extinguishing private property rights through a non-Article III forum without a jury.

The grant of certiorari in this case is particularly noteworthy given that the United States was asked by the Supreme Court for its views and opined in its brief that the petition should be denied. Generally speaking, the Supreme Court accepts the recommendations of the Solicitor, but this marks the second time in just several weeks where the Solicitor has recommended the Court decline certiorari in a patent case only to have the Court take the case any way. The other case where the Solicitor recommended the Court not get involved was SAS Institute v. Lee, dealing with the issue of whether the PTAB must issue a final written decision with respect to any claim that is challenged, as is actually required by statute. For more on that case see SCOTUS to hear SAS Institute v. Lee.

The argument that inter partes review is unconstitutional can be traced back all the way to 1898 when the Supreme Court issued its decision in McCormick Harvesting Mach. Co. v. Aultman & Co., 169 U.S. 606 (1898). In that case the Supreme Court held that once a patent is granted it “is not subject to be revoked or canceled by the president, or any other officer of the Government” because “t has become the property of the patentee, and as such is entitled to the same legal protection as other property.”

Since September 16, 2012, when the PTAB became operational and post grant challenges made available under the America Invents Act (AIA), the USPTO has been doing precisely what the Supreme Court in McCormick Harvesting said was prohibited – revoke patents. Therefore, the Supreme Court will either need to explicitly overrule McCormick Harvesting, implicitly overrule McCormick Harvesting while trying to convince themselves that the case remains good law and is consistent with AIA post grant procedures, or the Court will need to find inter partes review unconstitutional.

The phrasing of the question taken by the Supreme Court could be quite telling. Over the last several years 8 of the 9 Supreme Court Justices have signed on to an opinion that has recognized that a patent confers either an exclusive or valuable property right. Thus, it would hardly seem a stretch to suggest that the Court, or at least the required four Justices necessary to take a case, have some reason to suspect that the extinguishing of a exclusive, valuable property through a non-Article III forum without a jury violates the Constitution.

In Horne v. Department of Agriculture, Chief Justice John Roberts writing for the majority that included Justices Scalia, Kennedy, Thomas, Alito, as well as Ginsburg, Breyer and Kagan with respect to Parts I and II, approvingly quoted from James v. Campbell a 19th century case that unequivocally states that a patent confers upon the patent owner “exclusive property” rights. Moreover, in a dissent written by Justice Alito and joined by Justice Sotomayor in Cuozzo Speed Technologies v. Lee, footnote 6 calls a patent a “valuable property right.” Still further, in 2014, Nautilus v. Biosig Instruments, Justice Ginsburg, writing for a unanimous Court called the patent grant a reward of a patent a “property right” and “like any property right, its boundaries should be clear.” She was quoting the earlier Festo case, which had also been a unanimous 2002 decision. Thus, the Roberts Court has repeatedly identified patents as a property right, exclusive and valuable in nature. Indeed, a property right that is similar to other property rights. Combine this with the many Supreme Court cases from generations ago that routinely describe patents in inventions being equivalent to patents in land, and it seems as though there is real reason to suspect that the Supreme Court could rule inter partes review unconstitutional.

While many will undoubtedly have varied opinions as to the importance of this decision by the Court to take this case, the truth is that any decision by the Supreme Court in Oil States simply cannot make things any worse for patent owners than they already are. Patents rights are currently extinguished by an Article I tribunal that fundamentally refuses to provide even a modicum of due process. The PTAB refuses to consider evidence timely submitted, they refuse to allow amendments despite the statute saying there is a right to amend, they refuse to issue final decisions on all the claims challenged, they make up their own standards rather than follow statutory tests, there are no judicial rules of ethical conduct for PTAB judges, PTAB judges decide issues where there are serious conflicts of interest, and much more. Therefore, things could hardly get any worse, yet Oil States presents the very real possibility that the Supreme Court will rule that post grant proceedings at the USPTO violate the Constitution.

(For many patent owners, last week's Supreme Court ruling could be considered a negative ruling if their patents are removed from them by a PTAB ruling against the validity of their patents.

Interestingly for Strikeforce, the PTAB, in a rare ruling on October 17, 2017 completely in Strikeforce's favor on ALL challenges, provided HUGE credence to SFOR's patents. Now, the Supreme Court has upheld the PTAB process!
)

There will undoubtedly be much more written about this issue in the months to come. It will not be argued until the October 2017 term of the Court, with a decision sometime before the end of June 2018. Stay tuned!

We did stay tuned and we LOVE IT!!!

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 2

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 3

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 1

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 2

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 7

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 6

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 6

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 5

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading

Top 5 Most Recently Viewed Articles

Experience the Thrill of the 33rd UAE President Cup Event

Updated Category News Views 186

The Anticipation of the 33rd UAE President Cup Abu Dhabi Turf Club is gearing up for the highly anticipated 33rd edition of the President of the UAE Cup for Arabian Purebred Horses. Scheduled during the vibrant 2025–2026 season, this event shines a light on the rich culture and love for Arabian horses. The race will take place under the esteemed patronage of His...

Continue Reading
Dover Expands Product Line with Dryer Technology Acquisition

Updated Category News Views 147

Dover Expands Product Line with Dryer Technology Acquisition Dover, a notable player in the global manufacturing sector, recently announced a strategic acquisition centered on enhancing its technological capabilities. The company, which trades on the New York Stock Exchange under the ticker symbol DOV, has taken a significant step by acquiring specific assets from Carter...

Continue Reading
Gentex Corporation Secures Air Force Contract for Night Spectacles

Updated Category News Views 135

Gentex Corporation Awarded USAF Contract Gentex Corporation, a prominent name in personal protection and situational awareness solutions, has made significant strides with its latest achievement. The company recently received a contract to develop and produce the Aircrew Laser Eye Protection (ALEP) Night Spectacle for the United States Air Force. This contract marks an...

Continue Reading
Hyster-Yale Increases Dividend to Shareholders in Announcement

Updated Category News Views 145

Hyster-Yale Declares Increased Quarterly Dividend Hyster-Yale, Inc. (NYSE: HY) recently revealed that its Board of Directors has approved a rise in the regular cash dividend from 35 cents to 36 cents per share. This increase reflects the company’s commitment to providing value to its shareholders. Details of the Dividend Payment The increased dividend will be applicable...

Continue Reading
MediWound Enhances Production Capacity with New Facility

Updated Category News Views 141

MediWound Expands Manufacturing Capacity for NexoBrid MediWound Ltd., a pioneering company in the field of enzymatic therapeutics, has successfully completed the important commissioning process for its extended GMP manufacturing facility. This advancement marks a significant moment for the organization, setting the stage for achieving a remarkable sixfold increase in...

Continue Reading